Favorable research results from the PURPOSE 1 trial (South Africa and Uganda) have been published in the New England Journal of Medicine and presented at IAS 2024 in Munich, use …
This meeting is presented by the Office of HIV and AIDS Malignancy, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services will take place October 24, 25, at …